Latest Innovation News

Lumos Diagnostics has voluntarily suspended its ASX trading pending a market announcement about strategic agreements, signaling potential shifts in its business trajectory.

CleanSpace Holdings reports a robust 26% increase in FY25 revenue, driven by strong growth across Europe, North America, and APAC regions, underscoring its expanding footprint in industrial respiratory protection.

Ava Risk Group reports a 5% revenue increase and a positive EBITDA turnaround in FY25, underpinned by its advanced security technologies. The company eyes over $88 million in FY26 sales opportunities despite some project delays.

Ava Risk Group has suspended its dividend policy to reinvest capital into its growth strategy, signaling a shift in priorities for shareholders. The board will reassess this stance annually.

Biome Australia Limited has reported a 69% increase in international sales revenue for FY25, reaching $1.5 million, driven by new strategic distribution agreements across Ireland, New Zealand, and Canada.

HUB24 Limited has reported a record $19.8 billion in net inflows for FY25, driven by strong platform growth and significant migrations from Equity Trustees. The company also launched an innovative high net worth solution, reinforcing its market leadership.

Atturra Limited reports FY25 underlying EBITDA exceeding $31 million and revenue topping $300 million, setting the stage for a strong growth outlook in FY26 driven by acquisitions and product expansion.

Haranga Resources has successfully renewed its Saraya Uranium Project exploration permit in Senegal for another three years, following a positive regulatory audit. This extension secures ongoing exploration of a significant uranium resource with promising prospects.

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

Revolver Resources has completed critical engineering designs and secured over A$1 million in government grants and royalties, setting the stage for a targeted restart of copper production at its Dianne Copper Mine in late 2025.

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.

Locate Technologies has successfully raised $168,915 through its At-the-Market Facility, reinforcing its financial position as it continues to develop its delivery optimisation platforms.